comparemela.com

Latest Breaking News On - Simplicity wealth - Page 9 : comparemela.com

Waldencast (NASDAQ:WALD) Earns Outperform Rating from Telsey Advisory Group

Telsey Advisory Group restated their outperform rating on shares of Waldencast (NASDAQ:WALD – Free Report) in a research report report published on Tuesday, Benzinga reports. They currently have a $8.00 price objective on the stock. Waldencast Stock Up 2.7 % WALD stock opened at $4.18 on Tuesday. Waldencast has a one year low of $3.71 […]

Esperion Therapeutics (NASDAQ:ESPR) Given Buy Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) in a report issued on Tuesday, Benzinga reports. They currently have a $16.00 target price on the biopharmaceutical company’s stock. A number of other equities analysts also recently commented on the company. StockNews.com downgraded Esperion Therapeutics from a strong-buy rating […]

SSR Mining (NASDAQ:SSRM) Upgraded by StockNews com to Hold

SSR Mining (NASDAQ:SSRM) Upgraded by StockNews com to Hold
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

FingerMotion (NASDAQ:FNGR) Stock Price Up 6%

FingerMotion, Inc. (NASDAQ:FNGR – Get Free Report)’s share price rose 6% during mid-day trading on Tuesday . The stock traded as high as $3.20 and last traded at $3.18. Approximately 483,483 shares traded hands during mid-day trading, an increase of 44% from the average daily volume of 335,478 shares. The stock had previously closed at […]

Esperion Therapeutics (NASDAQ:ESPR) Earns Buy Rating from HC Wainwright

Esperion Therapeutics (NASDAQ:ESPR) Earns Buy Rating from HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.